Stratec SE

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
N/A
SEDOL
BYP2956
CIK
N/A
stratec.com
LEI: 529900ZZJWANAFSPGV30
©
FIGI: BBG000C52ZD0
SBS
Stratec SE
GICS: - · Sector: Laboratory devices · Sub-Sector: -
AI
PROFILER
NAME
Stratec SE
ISIN
DE000STRA555
TICKER
SBS
MIC
XETR
REUTERS
SBSG.DE
BLOOMBERG
SBS GR
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
TradingView ActivTrader MT4 MT5
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Fri, 25.10.2024

STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2024 Measures to enhance earnings show effect; at 8.4%, adjusted EBIT margin for 9M/2024 almost matches previous year’s level (9M/2023: 8.6%) despite negative scale effects Sales on a constant-currency basis -6.0% to € 176.3 million in 9M/2024 (9M/2023: € 187.7 million) Significantly improved sal...
Research & Analysis
Read more
Thu, 17.10.2024

STRATEC POSTS PRELIMINARY RESULTS FOR FIRST NINE MONTHS OF 2024; TARGET CORRIDOR FOR ADJUSTED EBIT MARGIN CONFIRMED WITH ADJUSTMENT TO 2024 SALES GUIDANCE Birkenfeld, October 17, 2024 Based on preliminary figures, STRATEC generated consolidated sales of € 176.3 million in the first nine months of 2024 (9M/2023: € 187.7 million). Its sales perform...
Research & Analysis
Read more
Fri, 09.08.2024

STRATEC POSTS RESULTS FOR FIRST HALF OF 2024 Considerably improved business dynamics in second quarter (sales Q2/2024: constant currency +5.3%); sales in H1/2024: constant currency -4.9% to € 119.1 million (H1/2023: € 125.0 million) Adjusted EBIT margin of 9.6% in Q2/2024 (Q2/2023: 4.9%); adjusted EBIT margin in H1/2024 improves by 260 basis poi...
Research & Analysis
Read more
Tue, 30.07.2024

STRATEC REPORTS CHANGES IN FINANCE DIVISION Birkenfeld, July 30, 2024 STRATEC SE, a leading manufacturer of automation solutions for partners in clinical diagnostics and life sciences, is reporting a change in the composition of its Board of Management. In agreement with the company, Dr. Robert Siegle, a member of the Board of Management of STR...
Research & Analysis
Read more
Fri, 17.05.2024

STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS Birkenfeld, May 17, 2024 Shareholders at today’s Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard, SDAX) approved all agenda items submitted for resolution with the necessary majority in each case. As proposed, STRATEC will enable its ...
Research & Analysis
Read more
Fri, 26.04.2024

STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024 Subdued start to financial year as expected, but noticeable revival apparent in market and very strong sales growth expected for second quarter of 2024 Consolidated sales Q1/2024 -15.7% at constant currency to € 50.9 million (Q1/2023: € 60.5 million) Efficiency measures and structural changes taki...
Research & Analysis
Read more
Thu, 28.03.2024

STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR Consolidated sales in 2023 -3.8% at constant currency to € 261.9 million (2022: € 274.6 million); Constant-currency growth of 12.9% in Q4/2023 Adjusted EBIT margin of 10.3% (2022: 16.4%) within guidance corridor New product launch and newly concluded development cooperations with partners 2024 gu...
Research & Analysis
Read more
Thu, 28.03.2024

STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR Consolidated sales in 2023 -3.8% at constant currency to € 261.9 million (2022: € 274.6 million); Constant-currency growth of 12.9% in Q4/2023 Adjusted EBIT margin of 10.3% (2022: 16.4%) within guidance corridor New product launch and newly concluded development cooperations with partners 2024 gu...
Research & Analysis
Read more
Thu, 21.03.2024

STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR Birkenfeld, March 21, 2024 The Supervisory Board and Board of Management of STRATEC plan to propose the distribution of a dividend of € 0.55 per share for the 2023 financial year for approval by the Annual General Meeting on May 17, 2024 (previous year: € 0.97 per sh...
Research & Analysis
Read more
Thu, 21.12.2023

STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Birkenfeld, December 21, 2023 STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at the Westin St. Francis in San Francisco, CA, USA. Marcus Wolfinge...
Research & Analysis
Read more
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S